2534-03-4
1572943-04-4
Tezepelumab
1270012-79-7
Efmoroctocog alfa
1380723-44-3
Atezolizumab
2713439-69-9
tert-Butyl ((S)-1-amino-1-oxo-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)carbamate
1261609-97-5
893420-59-2
2130869-18-8
Mal-PEG2-VCP-Eribulin
1227507-92-7
1610943-06-0
Emicizumab
1044511-01-4
Benralizumab
62515-68-6
2766584-67-0
1384260-65-4
Aducanumab
1599440-12-6
863971-12-4
MMAF-OMe
159847-82-2
1261456-41-0
1623109-08-9
943609-66-3
Vedolizumab
More Information:
Check CAS No 1572943-04-4 on External Site
1572943-04-4
tezepelumab,1572943-04-4
2025-12-25 Discover Tezepelumab (CAS No: 1572943-04-4) and related compounds. Ideal for advanced chemical applications. Competitive pricing, fast delivery, and expert support worldwide.